News and media

| 26/07/2016

Two papers published today in the prestigious journal Nature Genetics provide new insights on the genes predisposing to amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND). 

| 14/07/2016

MND Australia and the MND Association of Victoria are pleased to announce the 8th National MND Conference to be held in Melbourne on 12 September 2016. 

| 7/07/2016

MND NSW and MND Victoria have provided funding to support new motor neurone disease (MND) research projects in 2017, which will be awarded via the Motor Neurone Disease Research Institute of Australia (MNDRIA).

| 17/06/2016

Shadow Health Minister, Catherine King’s has announced a $5 million investment to support the crucial needs of Australians living with MND. 
 

| 14/06/2016

In the lead up to the Federal Election 2016, MND Australia seeks five commitments from our politicians to improve the lives of people living with MND and their families. Read the full MND Australia Action Framework.
 

 

| 8/06/2016

The May/June edition of MNDcare News is now available. Health professionals can catch up on the latest clinical information, research updates as well as upcoming conferences and events.

| 30/05/2016

The Motor Neurone Disease Research Institute of Australia is pleased to announce that applications for 2017 MNDRIA/NHMRC PhD Scholarships and PhD Top-up Grants are open.
 

| 25/05/2016

The Motor Neurone Disease Research Institute of Australia is pleased to announce applications are open for grants-in-aid and postdoctoral fellowships to start in 2017.

| 24/05/2016

MND Australia has won best Social Media Campaign of the Year for The Fading Symphony at the Australian Not-For-Profit Technology Awards 2016.

In accepting this award we acknowledge all people impacted by MND who motivate us every day and whose bravery inspired the wonderful pro-bono team that created the campaign.
 

| 9/05/2016

The Betty Laidlaw MND Research Grant has been awarded to University of Melbourne neuroscientist Dr Peter Crouch to lead a multicentre team working on a drug called copper-ATSM as a potential treatment for MND.